Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06001762 |
|---|---|
| Brief Title: | TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer |
| First Submitted : | August 14, 2023 |
| First Submitted that Met QC Criteria : | August 14, 2023 |
| First Posted : | August 21, 2023 |
| Last Update Submitted that Met QC Criteria : | March 25, 2024 |
| Last Update Posted : | March 26, 2024 |